KEGG   DRUG: Zeleciment rostudirsen
Entry
D13292                      Drug                                   
Name
Zeleciment rostudirsen (USAN/INN);
Zeleciment rostudirsen (genetical recombination) (JAN)
Efficacy
Restoring or replacing dystrophin
  Type
Antibody-antisense conjugate
Comment
Treatment of Duchenne muscular dystrophy
Target
DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366] (pre-mRNA exon51)
TFRC (CD71) [HSA:7037] [KO:K06503]
Brite
Target-based classification of drugs [BR:br08310]
 Peptidases and inhibitors
  Metallo peptidases
   Family M28
    TFRC (CD71)
     D13292  Zeleciment rostudirsen (USAN/INN)
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    DMD* [HSA_VAR:1756v1]
     D13292  Zeleciment rostudirsen (USAN/INN)
Other DBs
PubChem: 528318782
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system